TNG908 is a MTAP-cooperative cancer research[1].
[1]. K. Briggs, et al. TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor for the treatment of MTAP-deleted cancer.MOLECULAR TARGETED AGENTS 2| VOLUME 174, SUPPLEMENT 1,S84,OCTOBER 2022.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥1,872.00 | 现货 | 1 | |
| 5mg | ¥4,680.00 | 现货 | 1 |
















TNG908 is a MTAP-cooperative cancer research[1].
[1]. K. Briggs, et al. TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor for the treatment of MTAP-deleted cancer.MOLECULAR TARGETED AGENTS 2| VOLUME 174, SUPPLEMENT 1,S84,OCTOBER 2022.